International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12787864
Original Research Article
An Observational Study To Correlate HbA1c Values In Type 2 Diabetes Mellitus Patients With Central Corneal Thickness Using Non-Contact Specular Microscopy in A Tertiary Care Centre in Mandya
Published
Nov. 9, 2024
Abstract

Background: Diabetes mellitus is a chronic metabolic disorder that can lead to various ocular complications, including corneal changes. This study aimed to investigate the correlation between HbA1c levels, central corneal thickness (CCT), and corneal endothelial parameters in patients with type 2 diabetes mellitus using non-contact specular microscopy.Methods: This observational study included 181 patients with type 2 diabetes mellitus who underwent a comprehensive ophthalmic examination, including non-contact specular microscopy. The correlation between HbA1c levels, CCT, endothelial cell density (ECD), coefficient of variation (CV), and hexagonality (HEX) was analyzed. The association between the severity of diabetic retinopathy and corneal parameters was also evaluated.Results: A significant positive correlation was found between HbA1c levels and CCT (p6.5% had a mean CCT of 579.24±19.47 µm, compared to 537.73±16.92 µm in those with HbA1c levels between 4-5.6% (p<0.001). The duration of diabetes was also significantly associated with increased CCT (p<0.001). Patients with PDR had the lowest mean ECD (2091.88±121.34 cells/mm²), highest mean CV (51.01±4.78%), and lowest mean HEX (30.10±3.92%) compared to those with no diabetic retinopathy (p<0.001 for all).Conclusion: HbA1c levels and duration of diabetes significantly correlate with CCT and corneal endothelial changes in patients with type 2 diabetes mellitus. Non-contact specular microscopy is a valuable tool for detecting early corneal changes in diabetic patients, enabling timely intervention and prevention of visual impairment.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1898 Views
367 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved